What is a good amount of protein per day, and does it change when taking Glucagon-like peptide (GLP) medication, such as semaglutide (GLP-1 receptor agonist) or liraglutide (GLP-1 receptor agonist)?
2025;18(6):e70262
European RAVs database: Frequency and characteristics of RAVs in treatment-naive and DAA-experienced patients [Abstract PS007]
What patients need alongside a new format is clear information, realistic expectations, and care that supports them for the long term not just at the point of prescription
Current pharmacological interventions, including metformin and hormonal contraceptives, frequently fall short of addressing the full spectrum of PMOS pathophysiology
Can Lipo C injections help with stubborn fat or target specific areas? Lipo C injections accelerate systemic fat mobilisation and cannot target specific fat depots spot reduction through any intervention, including lipotropic compounds, is physiologically impossible